Litcius/Paper detail

Therapeutic treatment with Ibrutinib attenuates imiquimod-induced psoriasis-like inflammation in mice through downregulation of oxidative and inflammatory mediators in neutrophils and dendritic cells

Naif O. Al‐Harbi, Ahmed Nadeem, Sheikh F. Ahmad, Saleh A. Bakheet, Ahmed M. El‐Sherbeeny, Khalid E. Ibrahim, Khalid S. Alzahrani, Mohammed M. Al‐Harbi, Hafiz Majid Mahmood, Faleh Alqahtani, Sabry M. Attia, Moureq R. Alotaibi

2020European Journal of Pharmacology58 citationsDOI

Topics & Concepts

ImiquimodPsoriasisInflammationIbrutinibDownregulation and upregulationMedicineImmunologyPharmacologyChemistryLeukemiaGeneBiochemistryChronic lymphocytic leukemiaChronic Lymphocytic Leukemia ResearchPsoriasis: Treatment and PathogenesisAutoimmune Bullous Skin Diseases